Single Chain Peptide Agonists of Relaxin Receptors
Overview
Endocrinology
Molecular Biology
Affiliations
There are seven human relaxin family peptides that have two chains (A and B) and three disulfide bonds. The target receptors for four of these peptides are known as relaxin family peptide receptors, RXFP1-RXFP4. Detailed structure-activity relationship (SAR) studies of relaxin family peptides have been reported over the years and have led to the design of new analogs with agonistic and antagonistic properties. This review briefly summarizes the SAR of human relaxin 2 (H2 relaxin) and human relaxin 3 (H3 relaxin) leading to the design and development of single-B-chain only agonists, B7-33 and peptide 5. The physiological functions of these new peptides agonists in cellular and animal models are also described.
DErcole A, Nistri S, Pacini L, Carotenuto A, Santoro F, Papini A Front Pharmacol. 2022; 13:942178.
PMID: 36034864 PMC: 9402926. DOI: 10.3389/fphar.2022.942178.
Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay E, Guan D, Van Voorhies K, Vasukuttan V, Mathews K, Besheer J J Med Chem. 2022; 65(11):7959-7974.
PMID: 35594150 PMC: 9255433. DOI: 10.1021/acs.jmedchem.2c00508.
Abboud C, Brochoire L, Drouet A, Hossain M, Hleihel W, Gundlach A Pain Rep. 2021; 6(2):e937.
PMID: 34159282 PMC: 8213244. DOI: 10.1097/PR9.0000000000000937.
Effects of C-Terminal B-Chain Modifications in a Relaxin 3 Agonist Analogue.
Praveen P, Tailhades J, Rosengren K, Liu M, Wade J, Bathgate R ACS Med Chem Lett. 2020; 11(11):2336-2340.
PMID: 33214850 PMC: 7667869. DOI: 10.1021/acsmedchemlett.0c00456.
The future of bronchodilation: looking for new classes of bronchodilators.
Cazzola M, Rogliani P, Matera M Eur Respir Rev. 2019; 28(154).
PMID: 31871127 PMC: 9488694. DOI: 10.1183/16000617.0095-2019.